InvestorsObserver
×
News Home

Can Abbott Laboratories (ABT) Stock Rise to the Top of Healthcare Sector Monday?

Monday, November 22, 2021 03:06 PM | InvestorsObserver Analysts

Mentioned in this article

Can Abbott Laboratories (ABT) Stock Rise to the Top of Healthcare Sector Monday?

Abbott Laboratories (ABT) is near the top in its sector according to InvestorsObserver. ABT gets an overall rating of 53. That means it scores higher than 53% of stocks. Abbott Laboratories gets a 93 rank in the Healthcare sector. Healthcare is number 8 out of 11 sectors.

Overall Score - 53
ABT has an Overall Score of 53. Find out what this means to you and get the rest of the rankings on ABT!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Abbott Laboratories Stock Today?

Abbott Laboratories (ABT) stock is down -0.74% while the S&P 500 is up 0.64% as of 3:01 PM on Monday, Nov 22. ABT is lower by -$0.93 from the previous closing price of $126.83 on volume of 2,058,225 shares. Over the past year the S&P 500 is higher by 32.16% while ABT is up 15.21%. ABT earned $4.05 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 31.13. Click Here to get the full Stock Report for Abbott Laboratories stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App